To determine if suppression of Brn-2 leads to reduced invasion of breast cancer cells, we performed Matrigel transwell invasion assays using MDA-MB-231 cells that express BRN2-targeting dicer-substrate siRNA. Here, POU3F2 is linked to breast carcinoma.